Network bioinformatics analysis provides insight into drug repurposing for COVID-19
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...
Saved in:
Main Authors: | Xu Li (Author), Jinchao Yu (Author), Zhiming Zhang (Author), Jing Ren (Author), Alex E. Peluffo (Author), Wen Zhang (Author), Yujie Zhao (Author), Jiawei Wu (Author), Kaijing Yan (Author), Daniel Cohen (Author), Wenjia Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of Chronic Kidney Disease
by: Le-Ting Zhou, et al.
Published: (2018) -
Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for COVID‐19
by: Jiapeng Li, et al.
Published: (2022) -
Identification of microRNA-mRNA-TF regulatory networks in periodontitis by bioinformatics analysis
by: Xiaoli Gao, et al.
Published: (2022) -
Effects and mechanisms of puerarin against neuroblastoma: insights from bioinformatics and in vitro experiments
by: Xiaohui Sui, et al.
Published: (2024) -
Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis
by: Ulku Unal, et al.
Published: (2022)